In silico investigation of lysostaphin-producing novel strains as an enzybiotic against methicillin-resistant Staphylococcus aureus
The methicillin-resistant Staphylococcus aureus (MRSA) strain has attracted much attention as a health-threatening pathogen and there is an urgent need for finding new drugs. In the present study, an in silico approach was utilized to investigate lysostaphin as a novel enzybiotic against MRSA strain...
Main Authors: | Seyed Amir Hossein Mohammadzadeh Hosseini Moghri, Saeed Ghanbari Hassan Kiadeh, Somayeh Rahaiee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Informatics in Medicine Unlocked |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914821001131 |
Similar Items
-
In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
by: Nagalakshmi Narasimhaswamy, et al.
Published: (2017-11-01) -
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice
by: Hajiahmadi F, et al.
Published: (2019-07-01) -
In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model
by: Shabnam Sadoogh Abbasian, et al.
Published: (2023-04-01) -
The Prevalence of Methicillin-Resistant Staphylococcus aureus in Pastors Hospital in Bam
by: Asma Azizabadi, et al.
Published: (2019-06-01) -
Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA
by: Mackenzie Koeck, et al.
Published: (2019-01-01)